Zymeworks ZYME Earnings Call Transcripts

NASDAQ ZYME
$30.00 -1.46 (-4.64%)
As of: Nov 11, 2026 · 11:33 AM EST
2 earnings calls on file for Zymeworks, from Q4 2025 to Q1 2026. Each transcript opens in a new tab.
Latest earnings call

Zymeworks Q1 2026 Earnings Call

May 7, 2026 7,234 words · 31 min read
  • Kenneth H. GalbraithChair and CEO
  • [Name not stated but referenced as newly appointed]Chief Financial Officer
  • Sabeen MekanSVP and Chief Medical Officer
  • Paul A. MoorePresident and Chief Scientific Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Zymeworks Earnings Call Transcripts

Calls2
LatestMay 7, 2026
SinceQ4 2025

Fiscal 2026

Fiscal 2025

All 2 Zymeworks transcripts Register to get access to Zymeworks’s earnings call transcripts.